Skip to main content
Screener/Healthcare/Biotechnology

EXEL — Exelixis, Inc.

NASDAQ
$47.83+1.61 (+3.48%)
Large CapUnder $50HealthcareHigh ROELow BetaMost Profitable
$33.76
$49.62
$46.46
$47.88
EPS (TTM)$2.92
P/E Ratio16.38
Dividend Yield—
Market Cap$11.62B
Volume1.48M
Prev Close$46.21
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$598.7M$244.5M$0.8895.6%40.8%
Q3 '25$597.8M$193.6M$0.7096.9%32.4%
Q3 '26$597.8M$193.6M$0.6996.9%32.4%
Q2 '25$568.3M$184.8M$0.6596.6%32.5%
Q2 '26$568.3M$184.8M$0.6596.6%32.5%
Q1 '25$555.4M$159.6M$0.5596.5%28.7%
Q1 '26$555.4M$159.6M$0.5596.5%28.7%
Q4 '24$566.8M$139.9M$0.4796.5%24.7%
Get Your Daily Market Recap